期刊文献+

携带人FL、GM-CSF基因的裸DNA的抑瘤作用 被引量:2

Antitumor gene therapy mediated by naked DNA as a carrier of human FL and GM-CSF gene
下载PDF
导出
摘要 目的探讨可表达人FL和GM-CSF的裸DNA抑制小鼠移植肿瘤生长的作用.方法分别将带有信号肽序列的人FL和GM-CSF基因插入pcDNA3.1/zeo载体,构建分泌表达人FL和GM-CSF的治疗用表达载体,经Sephacryl S1000柱层析法纯化了重组表达质粒.用Western 印迹和ELISA法检测目的基因在293细胞中的表达,并用TF1细胞验证293细胞表达的GM-CSF的生物学活性.重组表达质粒与脂质体孵育形成复合物,隔天肌肉注射小鼠共6次,每只小鼠接种T细胞淋巴瘤细胞EL-4 2×105后,观察不同基因组合条件下肿瘤的生长情况.结果人FL和GM-CSF在293细胞中表达量分别为50 μg/L和30 μg/L,单用FL或GM-CSF和两者联用对肿瘤生长均有一定抑制作用,在第17天抑制率为30%~40%.联合应用组较单用FL或GM-CSF组更为有效抑制肿瘤生长,但小鼠生存时间并无延长.结论人FL和GM-CSF在293细胞中均获表达,且对肿瘤的早期生长具有一定的抑制作用,两者联合应用效果更为明显,但对小鼠最终生存时间并无影响. Objective This article investigated the antitumor effects mediated by naked DNA coding human FL and GM-CSF. Methods Two recombinant vectors containing human FL or GM-CSF genes, hFL-pcDNA3.1/Zeo and hGM-CSF-pcDNA3.1/Zeo, were constructed. A large scale plasmid DNA production and purification were followed by a size exclusion chromatography, Sephacryl S1000. The two recombinant plasmids and pcDNA3.1/Zeo were introduced into 293 cells, and the product was collected and tested by Western blotting and ELISA. The expressed hGM-CSF stimulated the proliferation of TF1 cells in vitro. A stable transfection complex was prepared by mixing plasmid DNA with a cation liposome, Lipofectamine 2000 and delivered to C57BL/6 mouse intramuscularly every second day. After a total of six injections, 2 ×10^5 EL-4 cells, a murine T-lymphoma (thymoma) cell line was inoculated into these mice subcutaneously and the antitumor effect of the complex was evaluated every two days. Results The expression amounts of FL and GM-CSF in 293 cells were 50μg/L and 30μg/L, respectively. Treatment with FL or GM-CSF alone and combination treatment of both factors can suppress the growth of the tumor between 30% - 40%. Conclusion The mice received expression vectors can suppress the growth of the tumor comparing with pcDNA3.1/Zeo, combinated application of both expression vectors showed more efficient antitumor effects. However, suppression of the growth of tumors failed to increase surviving days of these mouse.
出处 《基础医学与临床》 CSCD 北大核心 2005年第10期914-919,共6页 Basic and Clinical Medicine
基金 国家高技术研究发展计划项目(863项目)(2001AA212171)
关键词 人FL 人GM-CSF 免疫基因治疗 hFL hGM- CSF immunogene therapy
  • 相关文献

参考文献10

  • 1Lyman SD, James L, Vanden Bos T, et al. Molecular cloning of a ligand for the flt3/flk-2 tyrosine kinase receptor: a proliferative factor for primitive hematopoietic cells[J]. Cell, 1993, 75(6):1157-1167.
  • 2Maraskovsky E, Pulendran B, Brasel K, et al. Dramatic numerical increase of functionally mature dendritic cells in hFLT3 ligand-treated mice[J]. Adv Exp Med Biol, 1997,417: 33-40.
  • 3张友鸿,周希亚,陈松森,娄可佳,刘深基,杨克恭,何维.人FL在大肠杆菌中的表达及表达产物的纯化和生物学活性测定[J].基础医学与临床,2002,22(2):125-129. 被引量:1
  • 4Daro E, Butz E, Smith J, et al. Comparison of the functional properties of murine dendritic cells generated in vivo with Flt3 ligand, GM-CSF and Flt3 ligand plus GM-CSF[J]. Cytokine,2002,17(3):119 - 130.
  • 5马大龙.基因治疗的新型载体研究进展[J].基础医学与临床,2002,22(6):504-507. 被引量:11
  • 6Ferreira GN, Monteiro GA, Prazeres DM, et al. Downstream processing of plasmid DNA for gene therapy and DNA vaccine applications[J]. Trends Biotechnol, 2000,18(9): 380 - 388.
  • 7Prazeres DM, Ferreira GN, Monteiro GA, et al. Large-scale production of pharmaceutical-grade plasmid DNA for gene therapy: problems and bottlenecks[J]. Trends Biotechnol, 1999, 17(4): 169 - 174.
  • 8Sambrook J, Russell DW. Molecular Cloning: a laboratory manual[M]. 3rd ed. New York: Cold Spring Harbor Laboratory Press, 2001. A8.52-A8.55.
  • 9Lu QL, Bou-Gharios G, Partridge TA. Non-viral gene delivery in skeletal muscle: a protein factory[J]. Gene Ther,2003, 10(2):131-142.
  • 10Peron JM, Esche C, Subbotin VM, et al. FL33-1igand administration inhibits liver metastases: role of NK cells[J]. J Immunol, 1998,161(11):6164 - 6170.

二级参考文献6

共引文献10

同被引文献29

  • 1李川晟,程涛,许燕群.重组人干细胞因子对放射病患者造血细胞的体外作用[J].中华放射医学与防护杂志,1994,14(4):221-224. 被引量:8
  • 2Blechman JM,Lev S,Brizzi MF,et al.Soluble c-kit proteins and antireceptor monoclonal antibodies confine the binding site of the stem cell factor.J Biol Chem,1993,268 (6):4399-4406.
  • 3Dahlen DD,Lin NL,Liu YC,et al.Soluble Kit receptor blocks stem cell factor bioactivity in vitro.Leuk Res,2001,25(5):413-421.
  • 4Nakamura Y,Tajima F,Ishiga K,et al.Soluble c-kit receptor mobilizes hematopoietic stem cells to peripheral blood in mice.Exp Hematol,2004,32(4):390-396.
  • 5Takeshima H,Kuratsu J.A review of soluble c-kit (s-kit) as a novel tumor marker and possible molecular target for the treatment of CNS germinoma.Surg Neurol,2003,60 (4):321-324.
  • 6Novokhatny V,Medved L,Lijnen HR,et al.Tissue-type plasminogen activator (tPA) interacts with urokinase-type plasminogen activator (uPA) via tPA's lysine binding site.An explanation of the poor fibrin affinity of recombinant tPA/uPA chimeric molecules.J Biol Chem,1995,270(15):8680-8685.
  • 7Ishibashi M,Tokunaga H,Arakawa T,et al.Expression,purification,and characterization of the active immunoglobulinlike domain of human granulocyte-colony-stimulating factor receptor in Escherichia coli.Protein Expr Purif,2001,21 (2):317-322.
  • 8Singh SM,Panda AK.Solubilization and refolding of bacterial inclusion body proteins.J Biosci Bioeng,2005,99 (4):303-310.
  • 9Jungbauer A,Kaar W,Schlegl R.Folding and refolding of proteins in chromatographic beds.Curr Opin Biotechnol,2004,15(5):487-494.
  • 10Krystal GW,Hines SJ,Organ CP.Autocrine growth of small cell lung cancer mediated by coexpression of c-kit and stem cell factor.Cancer Res,1996,56(2):370-376.

引证文献2

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部